Turning Point Therapeutics Granted Fast-Track Designation for Repotrectinib in NTRK-Positive TKI-Pretreated Advanced Solid Tumors

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition